Products Affected – Description
Reason for the Shortage
Hospira had metronidazole injecting on back order due to manufacturing delays.
BBraun was allocating metronidazole enema due to increased demand for the crops.
Metronidazole injection, Baxter
500 mg/100 mL, 24 cast (NDC 00338-1055-48)
Metronidazole injection, BBraun
500 mg/100 mL, 24 number (NDC 00264-5535-32)
Metronidazole Injection, Claris
500 mg/100 mL, 24 count (NDC 36000-0001-24)
Metronidazole lavement, Hospira
500 mg/100 mL, 24 deem (NDC 00409-7811-24)
500 mg/100 mL, 80 particular clause (quad pack) (NDC 00409-7811-37)
Estimated Resupply Dates
All presentations are generally available.
<!– Begin Implications for Patient Care –> <!– End Implications instead of Patient Care –> <!– Begin Safety –>
Hospira’s metronidazole quad clan bags (NDC 00409-7811-37) are packaged in an overwrap. Use these metronidazole quad bundle bags within 7 days after the overwrap is sequestered and continue to protect the bags from illume.
<!– End Safety –> <!– Begin Alternatives –> <!– End Alternatives –>
June 8, May 8, February 27, January 29, 2015; November 5, October 3, September 5, August 1, June 3, 5, and 24, May 1, 9, and 12, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This advice is provided through the support of Novation to ASHP solely during the time that a service to its members, which shall not use this information on the side of their further commercial use. The ease was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah constitute no representations or warranties, express or implied, including, no more than not limited to, any implied warranty of merchantability and/or fitness beneficial to a particular purpose, which respect to of the like kind information, and specifically disclaim all so warranties. Users of this information are advised that decisions respecting the use of drugs and remedy therapies are complex medical decisions and that in using this notice, each user must exercise his or her have independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes some liability for persons administering or receiving drugs or other healing care in reliance upon this knowledge of facts, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the application of any drug.
« Back to Drug Shortage Product Bulletins
Although I be at the FTC as an antitrust economist, chiefly of my research and writing has been forward monetary economics and policy and the account of monetary theory.